Current Edition

cash

Pfizer asks hourly staffers to return overpayments in aftermath of vendor’s cyberattack: reports

A little extra cash is always a welcome surprise—until your employer asks you to pay it back, that is. In December, a ransomware attack struck …

Continue Reading →
cash

After failure, Zynerba shifts gears to save cash

Zynerba Pharmaceuticals on Thursday announced negative topline results from a Phase 1 safety and dosing study of its transdermal tetrahydrocannabinol patch ZYN001, sending shares down …

Continue Reading →